Related Experiment Video
Updated: Aug 5, 2026
12:24
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Myositis in Kawasaki disease
1Department of Pediatrics, University Hospital, Jacksonville, Florida 32209.
Pediatric Neurology
|March 1, 1990
Summary
Severe myositis is a rare neurologic complication of Kawasaki disease. Early recognition of muscle weakness and elevated creatine kinase levels is crucial for predicting severity and ensuring prompt respiratory support for patients.
Area of Science:
- Neurology
- Pediatrics
- Rheumatology
Background:
- Kawasaki disease (KD) is an acute febrile vasculitis affecting medium-sized arteries, primarily in children.
- Neurologic complications, including myositis, can occur in KD, though often remain undiagnosed.
Observation:
- This report details an unusual case of KD complicated by severe myositis and subsequent respiratory failure due to muscle weakness.
- Comparison with existing literature highlights that myositis in KD typically manifests 1-3 weeks after illness onset.
Findings:
- While often mild and unnoticed, KD-associated myositis can lead to significant muscle weakness and respiratory compromise.
- Elevated creatine kinase (CK) levels may serve as a valuable biomarker for predicting myopathy severity and the need for respiratory monitoring.
Implications:
- Physicians should consider myositis in the differential diagnosis of neurologic complications in Kawasaki disease.
- Close respiratory monitoring is essential in patients with KD-induced myositis, particularly those with elevated CK levels.
- Supportive therapy is the mainstay of treatment, with complete recovery anticipated.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...